Page last updated: 2024-11-03

procarbazine and Tuberculosis, Pulmonary

procarbazine has been researched along with Tuberculosis, Pulmonary in 1 studies

Procarbazine: An antineoplastic agent used primarily in combination with mechlorethamine, vincristine, and prednisone (the MOPP protocol) in the treatment of Hodgkin's disease.
procarbazine : A benzamide obtained by formal condensation of the carboxy group of 4-[(2-methylhydrazino)methyl]benzoic acid with the amino group of isopropylamine. An antineoplastic chemotherapy drug used for treatment of Hodgkin's lymphoma. Metabolism yields azo-procarbazine and hydrogen peroxide, which results in the breaking of DNA strands.

Tuberculosis, Pulmonary: MYCOBACTERIUM infections of the lung.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Morgenstern, D1
Fleischer, J1

Other Studies

1 other study available for procarbazine and Tuberculosis, Pulmonary

ArticleYear
[Changes in the lung in lymphogranulomatosis and the results of cytostatic treatment].
    Folia haematologica (Leipzig, Germany : 1928), 1974, Volume: 101, Issue:4

    Topics: Antibiotics, Antineoplastic; Cyclophosphamide; Diagnosis, Differential; Hodgkin Disease; Lung; Lymph

1974